New drugs for horses and production animals in 2017

作者：Emmerich Ilka Ute^*

来源：Tieraerztliche Praxis Ausgabe Grosstiere Nutztiere, 2018, 46(2): 95-100.

DOI：10.15653/TPG-180300

• Drugs
• registration
• Fluralaner
• Gamithromycin
• Tolfenamic Acid
• Tulathromycin
• food-producing animals
• horses

In 2017, no new active pharmaceutical ingredients were released on the German market for horses or food-producing animals. Four established veterinary active pharmaceutical ingredients became available for additional species: the ectoparasitic Fluralaner (Exzolt (R)) of the isoxazoline group was additionally authorized for chickens, the macrolide antibiotics Gamithromycin (Zactran (R)) and Tulathromycin (Draxxin (R)) for sheep and the nonsteroidal anti-inflammatory drug Tolfenamic Acid (Tolfedol (R)) from the fenamate group for cattle and pigs. Additionally, one drug with a new combination of active ingredients, one drug with a new pharmaceutical form and one drug with a new mode of administration have been launched on the market for horses and food-producing animals.

• 出版日期2018-4